Fulgent Genetics (FLGT) Change in Account Payables (2015 - 2026)
Fulgent Genetics (FLGT) posted Change in Account Payables of -$3.4 million for Q2 2026, down 737.01% sequentially from -$408000.0 in Q1 2026, and down 984.72% YoY from $386000.0 in Q2 2025.
Fulgent Genetics (FLGT) Change in Account Payables (2015 - 2026) Analysis & Trends
Fulgent Genetics has reported Change in Account Payables for 12 years, with the latest figure at -$3.4 million in Q2 2026.
- Quarterly Change in Account Payables fell 984.72% year-over-year to -$3.4 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$3.0 million (down 350.5% YoY) and the FY2025 annual result came in at $550000.0, down 82.06% from the prior year.
- Change in Account Payables retreated to -$3.4 million in Q2 2026 per FLGT's latest filing, from -$408000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $7.0 million in Q4 2022 and troughed at -$22.1 million in Q3 2022.
- A 5-year average of -$1.8 million and a median of -$326500.0 in 2024 frame the typical range for Change in Account Payables.
- The widest YoY moves for Change in Account Payables: up 318.23% in 2022, down 1860.21% in 2022.
- Over 5 years, Change in Account Payables stood at $7.0 million in 2022, then plunged by 98.16% to $129000.0 in 2023, then slumped by 726.36% to -$808000.0 in 2024, then soared by 214.36% to $924000.0 in 2025, then sank by 469.59% to -$3.4 million in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered -$3.4 million, -$408000.0, and $924000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | - |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | -38.00 Mn |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | -6.74 Mn |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 15.00 Mn |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | - |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | 21.88 Mn |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | 10.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 674,000.00 |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | - |
| 10 | Fulgent Genetics | 515.29 Mn | 258.26 Mn | 25.68 Mn | -3.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.42 Mn |
| Jun 30, 2026 | -3.42 Mn |
| Mar 31, 2026 | -408,000.00 |
| Mar 31, 2026 | -408,000.00 |
| Dec 31, 2025 | 924,000.00 |
| Dec 31, 2025 | 924,000.00 |
| Sep 30, 2025 | -102,000.00 |
| Sep 30, 2025 | -102,000.00 |
| Jun 30, 2025 | 386,000.00 |
| Jun 30, 2025 | 386,000.00 |
| Mar 31, 2025 | -658,000.00 |
| Mar 31, 2025 | -658,000.00 |
| Dec 31, 2024 | -808,000.00 |
| Dec 31, 2024 | -808,000.00 |
| Sep 30, 2024 | 2.28 Mn |
| Sep 30, 2024 | 2.28 Mn |
| Jun 30, 2024 | 1.84 Mn |
| Jun 30, 2024 | 1.84 Mn |
| Mar 31, 2024 | -245,000.00 |
| Mar 31, 2024 | -245,000.00 |